Dyslexia is a common and potentially disabling disability that affects a large number of people, and it is now recognised as a serious medical condition.
In 2016, the US government launched the first national study to assess the effectiveness of a new class of medication known as Dyslexicon, which was designed to improve reading and comprehension.
The study is still ongoing, but a new study published in Science suggests that Dyslexic individuals are at a greater risk of developing diabetes, obesity and other chronic conditions.
In the study, the researchers looked at the outcomes of 1,600 people with Dyslexias, with the average age of participants being between 24 and 50.
They found that the average number of prescriptions they were prescribed for each of the conditions was four times higher than those who did not have dyslexias.
The researchers also looked at participants who had received DyslexiCal medication and found that, for all conditions, Dyslexics were more likely to have received a diagnosis of Type 2 Diabetes than those without dyslexic symptoms.
It is important to note that the research has not been designed to examine whether Dyslexiacs are more likely than others to develop diabetes or other chronic illnesses, but the researchers say that their findings suggest that Dyscalculi treatments are more effective for this condition.
The study was funded by the US Department of Veterans Affairs, and is available at the Scientific American website here.
Follow Scientist on Twitter and Facebook
